Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Biopharma’s bolt-on bonanza is set to continue
EP Vantage
Thu, 01/12/23 - 10:18 am
M&A
Amgen
AstraZeneca
Bristol Myers Squibb
GSK
Ipsen
Merck
Pfizer
Merck Highlights Growth Strategy at J.P. Morgan
BioSpace
Tue, 01/10/23 - 06:48 pm
Merck
JPMHC 2023
Keytruda
vaccines
M&A
JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals
Fierce Pharma
Tue, 01/10/23 - 10:50 am
JPMHC 2023
Takeda
vaccines
Roche
GSK
Bayer
Merck
Novo Nordisk, AstraZeneca and Lilly will top pharma's revenue growth in 2023: report
Fierce Pharma
Sun, 01/8/23 - 09:57 pm
Pfizer
Merck
JNJ
Novo Nordisk
AstraZeneca
The biggest-selling pharma companies of 2023
EP Vantage
Wed, 01/4/23 - 05:20 pm
Pfizer
Merck
JNJ
Novartis
AbbVie
Roche
Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts
Fierce Pharma
Tue, 01/3/23 - 10:10 am
Eli Lilly
Merck
PeptiDreams
peptides
drug delivery
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
Biopharma Reporter
Mon, 01/2/23 - 06:41 pm
antibody-drug conjugate
Merck
LegoChem Biosciences
Mersana
Amgen
GSK
Janssen
OncoC4 doses first participant in ovarian cancer therapy trial
Clinical Trials Arena
Mon, 01/2/23 - 06:33 pm
OncoC4
clinical trials
ONC-392
Merck
Keytruda
ovarian cancer
platinum-resistant ovarian cancer
Merck Expands ADC Footprint with $9.3B Kelun Licensing Deal
BioSpace
Thu, 12/22/22 - 10:44 am
Merck
China
Kelun-Biotech
antibody-drug conjugate
oncology
AstraZeneca, Merck's Lynparza wins EU nod in advanced prostate cancer right after FDA delay
Fierce Pharma
Wed, 12/21/22 - 12:40 pm
AstraZeneca
Merck
Lynparza
Europe
prostate cancer
advanced prostate cancer
Merck & Co. bails on NGM eye disease collab in wake of phase 2 fail
Fierce Biotech
Wed, 12/21/22 - 11:29 am
Merck
NGM Biopharmaceuticals
clinical trials
eye disease
NGM621
geographic atrophy
AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer
Fierce Pharma
Thu, 12/15/22 - 11:01 am
AstraZeneca
Merck
Lynparza
FDA
metastatic castration-resistant prostate cancer
Moderna, Merck & Co. mRNA cancer vaccine slashes melanoma recurrence in Keytruda combo trial
Fierce Biotech
Tue, 12/13/22 - 10:35 am
Merck
Moderna Therapeutics
MRNA
cancer immunotherapy
Keytruda
melanoma
Merck initiates cash tender offer to buy Imago BioSciences
Pharmaceutical Business Review
Tue, 12/13/22 - 10:26 am
Merck
M&A
Imago BioSciences
Setting the Stage for ASH 2022
BioSpace
Fri, 12/9/22 - 10:50 am
ASH 2022
AstraZeneca
Janssen
Merck
Vega Therapeutics
Mirati to focus adagrasib/Keytruda study in low PDL1 lung cancer patients
Yahoo/Reuters
Tue, 12/6/22 - 10:21 am
Mirati Therapeutics
adagrasib
Merck
Keytruda
metastatic lung cancer
lung cancer
GSK unveils Keytruda head-to-head data in lung cancer—and they look good at first glance
Fierce Pharma
Wed, 11/30/22 - 07:58 pm
GSK
Merck
Jemperli
Keytruda
clinical trials
non-small cell lung cancer
Merck to Leverage BigHat's AI Platform in 3 Drug Discovery Programs
BioSpace
Tue, 11/29/22 - 08:25 pm
Merck
BigHat Biosciences
R&D
artificial intelligence
Merck scores another win for Keytruda, this time in HER2-negative cancer
Endpoints
Tue, 11/22/22 - 04:39 pm
Merck
Keytruda
clinical trials
adenocarcinoma
Merck & Co. inks $1.4B blood cancer biotech buyout to muscle in on Bristol Myers, Novartis
Fierce Biotech
Mon, 11/21/22 - 10:34 am
Merck
M&A
Imago BioSciences
blood cancer
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »